Literature DB >> 11897649

Limited transmission of multidrug-resistant tuberculosis despite a high proportion of infectious cases in Los Angeles County, California.

Annette T Nitta1, Laura S Knowles, Jaimin Kim, Eleanor L Lehnkering, Lee A Borenstein, Paul T Davidson, Sydney M Harvey, Muriel L De Koning.   

Abstract

Preventing transmission of multidrug-resistant tuberculosis is critical because of treatment toxicity, cost, and the lack of effective therapy for latent infection. We attempted to determine the extent of transmission in Los Angeles County by comparing relatedness of multidrug-resistant tuberculosis cases using restriction fragment length polymorphism and by cross-matching contact information to the Tuberculosis Registry. Strain typing was done on isolates of 102 pulmonary multidrug-resistant cases identified between August 1993 and 1998. Seventy-one (70%) of the cases had cavitary lesions on chest radiograph, and 94 (92%) had sputa smear-positive for acid fast bacilli. Fifteen (15%) of the cases were known to be infected with human immunodeficiency virus. Four molecular clusters of two cases each and one closely related pair were identified among the 102 cases; contact investigation successfully identified all clusters but one. Among 946 contacts identified and cross-matched with the county's Tuberculosis Registry, one secondary case due to drug-resistant Mycobacterium bovis was found. To summarize, a very high proportion of pulmonary multidrug-resistant tuberculosis cases in Los Angeles County were infectious. Molecular strain typing indicated limited spread of disease, although it underestimated transmission compared with contact investigation. We believe aggressive surveillance and case management were critical to limiting the spread of multidrug- resistant tuberculosis.

Entities:  

Mesh:

Year:  2002        PMID: 11897649     DOI: 10.1164/ajrccm.165.6.2103109

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

1.  Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain.

Authors:  S Samper; M J Iglesias; M J Rabanaque; L I Gómez; M C Lafoz; M S Jiménez; A Ortega; M A Lezcano; D Van Soolingen; C Martín
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Laboratory Cross-Contamination of Mycobacterium tuberculosis: A Systematic Review and Meta-analysis.

Authors:  Aleksandra Barac; Hannah Karimzadeh-Esfahani; Mahya Pourostadi; Mohammad Taghi Rahimi; Ehsan Ahmadpour; Jalil Rashedi; Behroz Mahdavipoor; Hossein Samadi Kafil; Adel Spotin; Kalkidan Hassen Abate; Alexander G Mathioudakis; Mohammad Asgharzadeh
Journal:  Lung       Date:  2019-06-15       Impact factor: 2.584

3.  Molecular epidemiology of multidrug-resistant Mycobacterium bovis isolates with the same spoligotyping profile as isolates from animals.

Authors:  Beatriz Romero; Alicia Aranaz; Lucía de Juan; Julio Alvarez; Javier Bezos; Ana Mateos; Enrique Gómez-Mampaso; Lucas Domínguez
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

4.  A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Authors:  T Jagielski; A Brzostek; A van Belkum; J Dziadek; E Augustynowicz-Kopeć; Z Zwolska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-20       Impact factor: 3.267

5.  Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis.

Authors:  Ulf R Dahle; Per Sandven; Einar Heldal; Turid Mannsaaker; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

6.  Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study.

Authors:  Patrick K Moonan; Larry D Teeter; Katya Salcedo; Smita Ghosh; Shama D Ahuja; Jennifer Flood; Edward A Graviss
Journal:  Lancet Infect Dis       Date:  2013-06-05       Impact factor: 25.071

Review 7.  Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

Authors:  Suzanne M Marks; Sundari R Mase; Sapna Bamrah Morris
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

8.  Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007.

Authors:  John Z Metcalfe; Elizabeth Y Kim; S-Y Grace Lin; Adithya Cattamanchi; Peter Oh; Jennifer Flood; Philip C Hopewell; Midori Kato-Maeda
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

9.  Tuberculosis Control and Role of Molecular Epidemiology Studies in Iran: A Systematic Review.

Authors:  Mahya Pourostadi; Jalil Rashedi; Behroz Mahdavi Poor; Hossein Samadi Kafil; Abdolhassan Kazemi; Mohammad Asgharzadeh
Journal:  Tanaffos       Date:  2017

10.  Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting.

Authors:  James Johnston; Andrew Admon; Amir Ibrahim; Kevin Elwood; Patrick Tang; Victoria Cook; Mark Fitzgerald
Journal:  BMC Infect Dis       Date:  2012-10-22       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.